MetGen Oy is an innovative SME which designs, develops, supplies and markets novel enzymatic solutions and technologies around them for the most challenging of industrial conditions to meet our customer specific need. MetGen was found in 2008 and is based in Kaarina, Finland. MetGen is currently backed by some of the leading venture capital investors.
MetGen’s enzyme products – MetZyme®- are industrial, highly-active, natural catalyst that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and combination with other enzymes. MetGen products are protected by international patents. MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates. MetGen patents the proteins developed by them in order to give legal protection to company’s strategic objective to produce and market industrial enzymes. MetGen has invented a disruptive technology ENZINE® to develop industrial enzymes.
MetGen has achieved successful industrial trials with sector leaders in forest and renewable chemicals and aims to be a widely recognized supplier of industrial enzymes, significantly contributing to the economics and sustainability of process industries such as pulp & paper, biofuels and biochemicals. Another revolutionable technology introduced by MetGen is the METNIN™ enzymatic lignin fractionation technology. METNIN™ is developed to refine lignin to end-user specific characteristics. Our objective is to enable full valorization of lignin in chemical and material applications. This will make the products we use more sustainable, reduce the use of petroleum and plastics, as well as help fighting climate change by capturing CO2.
MetGen is readily prepared to address the full value-chain in bioprocessing - from pretreatment of substrate through hydrolysis and utilization of sugars to bioconversion and valorisation of side streams - with its MetZyme® product portfolio.